A large percentage of drug makers, universities, and hospitals continue to fail to publicly post clinical trials results, according to new data released by European officials, who took the opportunity...

Seeking to recover costs attributed to the opioid crisis, Minnesota has adopted a first-of-its kind law that requires drug makers and wholesalers that market the addictive painkillers to pay various...

[ad_1] Underscoring concerns about ongoing drug shortages, two different ventures representing hundreds of hospitals across the U.S. are announcing separate deals on Wednesday in which manufacturers have agreed to provide...

[ad_1] BOSTON — Attorneys general from more than 40 states are alleging the nation’s largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different...

[ad_1] In an unexpected move, the Food and Drug Administration has decided that biosimilar medicines should have distinct naming features from brand-name biologics in order to bolster patient safety, a...